SOLUBLE GUANYLATE CYCLATE ACTIVATORS FOR TREATING SYSTEMIC SCLEROSIS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240174653A1
SERIAL NO

18386267

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods for treating patients with systemic sclerosis, comprising administering to a patient in need thereof a therapeutically effective amount of a soluble guanylate cyclase (sGC) activator of formula (I),

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BOEHRINGER INGELHEIM PHARMACEUTICALS INC900 RIDGEBURY ROAD P O BOX 368 RIDGEFIELD CT 06877-0368

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FLACK, Mary Ruth New York, US 5 8
KAUFMAN, Julia Eastchester, US 1 0
SETHY-CORACI, Indra Ridgefield, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation